|

Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs

RECRUITINGN/ASponsored by H. Lee Moffitt Cancer Center and Research Institute
Actively Recruiting
PhaseN/A
SponsorH. Lee Moffitt Cancer Center and Research Institute
Started2025-10-10
Est. completion2030-10-10
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT07222995

Summary

The purpose of this study is to examine how different messages about risk of skin cancer can impact the uptake of skin cancer prevention activities.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Be a patient of any race or ethnicity attending one of the six Tampa Family Health Centers.
* Be 18 years of age or older.
* Self-report skin cancer risk behaviors within the past 12 months, including: Intentional sun exposure (e.g., outdoor or indoor tanning) or unintentional sun exposure leading to sunburn.
* Be willing to complete a baseline questionnaire and provide a saliva sample for MC1R genotyping.
* Be able to provide informed consent (written or electronic).
* Prefer English or Spanish for communication and study materials.

Exclusion Criteria:

* Do not report any skin cancer risk behaviors (i.e., no tanning or sunburning in the past 12 months).
* Are unwilling or unable to complete the baseline assessment or return the saliva kit.
* Decline to provide informed consent.
* Are under 18 years of age.

Conditions2

CancerSkin Cancer

Locations2 sites

Florida

1 site
Moffitt Cancer Center
Tampa, Florida, 33612
Peter Kanetsky, PhD, MPH

New York

1 site
Memorial Sloan Kettering Cancer Center
New York, New York, 10065

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.